Phase 2Starting soon
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
Sponsored by Biomed Industries, Inc.
About this study
A phase 2 study to assess the efficacy of NA-931 alone or in addition to Tirzepatide to assess efficacy and safety in overweight or obese men and women
Enrolling at this location
Biomed Research Unit # 92121-103
San Diego, California
I'm interestedThis study also enrolls at 7 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.